Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients

Many questions concerning responders (R) and nonresponders (NR) in severe eosinophilic asthma (SEA) after blocking the IL-5 (interleukin 5) pathway are still not clear, especially regarding the early parameters of response to biologics in personalized treatment strategies. We evaluated 17 SEA patien...

Full description

Bibliographic Details
Main Authors: Maruša Kopač Šokić, Matija Rijavec, Peter Korošec, Urška Bidovec-Stojkovič, Izidor Kern, Romana Vantur, Sabina Škrgat
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/1/70